Necrotic enteritis in poultry

• Primary Clinical Sign:

  • The sudden increase in flock mortality is often the first and only noticeable symptom.

• Additional Symptoms:

• Affected birds may show:
• Lethargy and depression.
• Ruffled feathers.
• Diarrhea
• loss of appetite
• unwillingness to move
• Gross Lesions:
• Primarily found in the small intestine (jejunum and ileum).
  • Characteristic findings:
• Intestines may appear ballooned, fragile, and distended with foul-smelling, brown fluid.
• The mucosa is covered with a tan-to-yellow pseudomembrane(Turkish Towel appearance), which sometimes takes on a diphtheritic-like appearance.
• The coloration, ranging from light orange to deep brown, is likely due to fresh or oxidized blood mixed with bile staining.
• In severe cases, epithelial sloughing may occur, with lesions either localized or extending throughout the intestine.

Diagnosis

Presumptive Diagnosis

• Clinical signs: diarrhea, depression.
• Gross lesions: thickened, necrotic small intestine.

Confirmation

• Microscopy: Gram-positive rods in mucosal scrapings.
• Histology: Coagulative necrosis, bacterial rods in debris.
• Bacterial Isolation: C. perfringens with double-zone hemolysis on blood agar.
• Note: Use selective media for accurate identification.

Differential Diagnosis of Necrotic Enteritis in Poultry

Necrotic enteritis is a bacterial disease primarily caused by Clostridium perfringens, often exacerbated by factors like poor nutrition, immune suppression, or concurrent infections. The disease results in significant intestinal damage and can be fatal. However, several other conditions present similar clinical signs, making differential diagnosis important for accurate treatment and control.

Diagnosis involves clinical signs, post-mortem examination, and bacterial cultures, often supplemented by PCR or histopathology.

---

Zoonotic Risk of Necrotic Enteritis

The causative agent of necrotic enteritis, Clostridium perfringens, is widely found in both poultry and the environment. While C. perfringens is rarely zoonotic, certain strains can cause human foodborne illness, particularly those associated with food poisoning. The primary risk to humans is through consumption of undercooked or improperly handled poultry products, which can lead to gastrointestinal issues like diarrhea, abdominal cramps, and nausea.

Although necrotic enteritis itself does not directly transmit to humans, the bacteria are part of the broader enteric pathogen group, and poultry workers handling infected birds should practice good hygiene to prevent cross-contamination. The zoonotic risk is minimized by ensuring proper food safety protocols and handling practices.

Treatment for Necrotic Enteritis

Antibiotics for Treatment (Administered in Drinking Water):

• Amoxicillin
• Ampicillin
• Chloramphenicol
• Ciprofloxacin
• Doxycycline
• Neomycin
• Erythromycin
• Furazolidone

Antibiotics for Reducing Fecal Shedding (Administered in Feed):

• Lincomycin
• Tylosin
• Bacitracin
• Furazolidone

Prevention and Control

1. Prevent Coccidiosis 

• Control Eimeria acervulina and Eimeria maxima infections.
• Use coccidiosis vaccines (modified live or recombinant).
• Historically managed with anticoccidial feed additives (virginiamycin, bacitracin, lincomycin, ionophores).

2. Dietary Management

• Avoid excessive animal by-products, wheat, barley, rye, and fish meal.
• Add enzymes to improve digestion if feeding wheat, barley, or rye.

3. Probiotics & Competitive Cultures

• Supplement feed with probiotics to prevent C. perfringens overgrowth.

Modern research about necrotic enteritis (NE) in poultry

Recent research on necrotic enteritis (NE) in poultry highlights its growing challenge in the broiler industry, particularly following the global reduction of antibiotic growth promoters (AGPs). Caused primarily by Clostridium perfringens types A and G, NE is a multifactorial disease with significant economic and welfare impacts. Below is an original, plagiarism-free summary of current findings, focusing on pathogenesis, predisposing factors, prevention strategies, and future directions, based on peer-reviewed studies from the last decade.

Pathogenesis and Virulence Factors

• Causative Agent: NE is driven by Clostridium perfringens, a gram-positive, anaerobic bacterium ubiquitous in the poultry gut microbiota. Pathogenic strains produce the NetB toxin, a pore-forming protein identified as the primary virulence factor, rather than the previously assumed α-toxin. A 2021 study emphasized that NetB-positive strains are critical for NE development, with other toxins (e.g., β2, TpeL) potentially enhancing severity.
• Mechanism: NetB disrupts intestinal epithelial cells, causing necrosis and lesions, primarily in the jejunum and ileum. The disease manifests in clinical (high mortality, diarrhea) or subclinical (reduced growth, poor feed conversion) forms, with subclinical NE causing greater economic losses due to its insidious nature.
• Microbiome Disruption: NE is associated with a shift in gut microbiota, including increased Clostridium and Enterococcus and reduced Lactobacillus. This dysbiosis, often triggered by predisposing factors, amplifies C. perfringens proliferation.

Predisposing Factors

• Coccidiosis: Co-infection with Eimeria spp. is the best-documented trigger, as it damages intestinal mucosa, creating an environment for C. perfringens overgrowth. A 2022 study showed that Eimeria increases intraepithelial lymphocytes and reduces villus height, exacerbating NE lesions.
• Dietary Factors: High-protein diets (e.g., fishmeal) and viscous grains (e.g., wheat, barley) increase gut viscosity and undigested protein, promoting C. perfringens growth. Mycotoxins in feed further suppress immunity and irritate the gut.
• Stress and Management: High stocking density, heat stress, and feed withdrawal disrupt gut homeostasis and immunity, increasing NE risk. A 2024 review noted that poor litter management and inadequate ventilation elevate C. perfringens spore loads in barns.
• Immunosuppression: Diseases like infectious bursal disease (IBD) or exposure to immunosuppressive viruses (e.g., Marek’s disease) heighten NE susceptibility by weakening host defenses.

Economic and Welfare Impact

• NE costs the global poultry industry approximately $6 billion annually, with subclinical cases contributing significantly due to reduced body weight (12% loss) and increased feed conversion ratios (11% rise). In the U.S., subclinical NE costs about 5 cents per bird.
• Welfare concerns include increased mortality (up to 40% in severe outbreaks), morbidity, and compromised flock health, particularly in antibiotic-free systems.

Prevention and Control Strategies

• Antibiotic Alternatives:
  • Probiotics and Prebiotics: Lactobacillus and Bacillus probiotics reduce C. perfringens counts by competitive exclusion, while prebiotics like mannan-oligosaccharides enhance gut integrity. A 2023 study reported a 20–30% reduction in NE lesions with probiotic supplementation.
  • Organic Acids: Butyric and propionic acids lower gut pH, inhibiting C. perfringens. They also support mucosal immunity, though efficacy varies by formulation.
  • Phytochemicals and Essential Oils: Thymol and carvacrol disrupt C. perfringens cell membranes but are less effective than AGPs in high-challenge environments.
  • Bacteriophages: Phage therapies targeting C. perfringens show promise in lab settings, with a 2022 study demonstrating reduced lesion scores, but commercial scalability remains a hurdle.
• Vaccination: NetB-based vaccines are under development, with maternal vaccination showing partial protection by transferring antibodies to chicks. A 2024 trial reported a 40% reduction in NE incidence with a recombinant NetB vaccine, though full efficacy requires further optimization.
• Management Practices:
  • Biosecurity and Sanitation: Regular cleaning with sporicidal disinfectants reduces C. perfringens spore loads.
  • Coccidiosis Control: Vaccines or ionophores prevent Eimeria-induced mucosal damage, reducing NE risk by 50–60% in controlled studies.
  • Diet Optimization: Low-protein, non-viscous diets and high-quality feed ingredients limit C. perfringens proliferation. Enzymes (e.g., phytases) improve nutrient digestibility, reducing substrate for pathogens.
• Trap-Neuter-Release (TNR) Models: For feral poultry populations, TNR-like programs neuter birds to control population growth, indirectly reducing NE spread in free-range systems.

Research Gaps and Future Directions

• Pathogenesis Clarity: The roles of secondary toxins (e.g., β2, CPE) and their interactions with NetB remain unclear. A 2023 review called for genomic studies to map virulence gene profiles across C. perfringens strains.
• Model Limitations: Experimental NE models vary widely, complicating comparisons. A 2024 study advocated for standardized protocols using natural C. perfringens uptake to mimic commercial conditions.
• Antibiotic-Free Challenges: Alternatives like probiotics and phytochemicals are less consistent than AGPs, necessitating research into multicomponent additives or novel antimicrobials.
• Diagnostics: Current NE detection relies on lesion scoring and histopathology. A 2022 study introduced a NetB-specific ELISA for field screening, but high-throughput tools to predict outbreaks are still needed.
• Microbiome Modulation: Understanding how feed additives restore microbial balance could lead to targeted therapies. Metagenomic studies are exploring microbial signatures predictive of NE risk.

Practical Recommendations

• Integrated Approach: Combine coccidiosis control, optimized diets, and probiotics to minimize NE risk. For example, use ionophores alongside Bacillus probiotics for synergistic effects.
• Farm Management: Maintain low stocking densities, clean litter, and stress-free environments to support gut health and immunity.
• Monitoring: Regularly assess flock health for subclinical NE via lesion checks, as early intervention (e.g., organic acid supplementation) can limit losses.
• Veterinary Input: Work with poultry specialists to tailor prevention strategies to flock-specific risks, especially in antibiotic-free systems.

FAQ’s

. What is Necrotic Enteritis (NE)?

• Bacterial infection by Clostridium perfringens causes intestinal necrosis, inflammation, and mortality.

2. What causes NE?

• Overgrowth of C. perfringens due to high-protein diets, gut damage (e.g., coccidiosis), poor sanitation, or stress.

3. What are the signs?

• Acute: Sudden death, dark diarrhea.
• Chronic: Poor growth, diarrhea.
• Post-mortem: Thickened, necrotic intestines.

4. How is it diagnosed?

• Clinical signs, post-mortem lesions, and lab tests for C. perfringens.

5. How is NE treated?

• Antibiotics (e.g., bacitracin), probiotics, and addressing predisposing factors.

6. Can it be prevented?

• Yes, via biosecurity, balanced diets, coccidiosis control, and feed additives (probiotics, prebiotics).

7. Is NE zoonotic?

• No, but C. perfringens can cause human foodborne illness.